Alina Sehar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alina Sehar has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Hassam Ali
Department of Gastroenterology, Hepatology and Nutrition, East Carolina University/Brody School of Medicine, Greenville, NC
2 shared publications - Abdul Moiz Sahito
Dow University Of Health Sciences Karachi Pakistan
1 shared publication - Abhay Thandavaram
Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA
1 shared publication - Ahmad Zain
Department of Internal Medicine, UCHealth Parkview Medical Center, Pueblo, CO
1 shared publication - Ali Shah
Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK
1 shared publication - Allahdad Khan
Department of Medicine, Nishtar Medical University, Multan, Pakistan
1 shared publication
Latest Publications
- Open Access
- 29 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science – Atherosclerotic Diseases
- Vol. 10 (1) , 211-219
Trends in mortality from acute myocardial infarction among the obese population in the United States from 1999 to 2020: insights from CDC WONDER
Introduction: Acute myocardial infarction (AMI) remains a leading cause of death globally, with obesity identified as a significant risk factor for increased incidence and poorer post-event outcomes. Understanding trends in AMI mortality among obese populations is crucial for informing public health strategies, especially in light of rising obesity rates.Material and methods: This retrospective study analyzed data from the CDC WONDER database to examine AMI-related mortality among obese individuals (ICD-10 codes I21 for AMI and E66 for obesity) from 1999 to 2020. Mortality rates were assessed using crude mortality rates (CMR) and age-adjusted mortality rates (AAMR) per 100,000, stratified by year, gender, race/ethnicity, state, and urban-rural status. Average annual percent change (AAPC) was calculated to identify trends over the study period.Results: From 1999 to 2020, there were 39,793 obesity-related AMI deaths. The AAPC for the entire period was 1.75 (95% CI: 1.06 to 2.45, p < 0.001). For men, the AAPC was 2.81, while for women, it was 1.12. Notably, African American individuals saw a significant increase in AMI mortality from 2018 to 2020 (AAPC = 19.28). Geographically, the Midwest, South, and West regions experienced upward trends, while the Northeast saw a slight decline. Smaller metropolitan and non-metropolitan areas showed consistent increases.Conclusions: The study highlights an upward trend in AMI-related mortality among the obese population in the U.S. from 1999 to 2020. Targeted public health interventions are needed to address these trends, particularly in high-risk populations.
- 29 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science – Atherosclerotic Diseases
- Vol. 10 (1) , 211-219
Open AccessTrends in mortality from acute myocardial infarction among the obese population in the United States from 1999 to 2020: insights from CDC WONDER
Introduction: Acute myocardial infarction (AMI) remains a leading cause of death globally, with obesity identified as a significant risk factor for increased incidence and poorer post-event outcomes. Understanding trends in AMI mortality among obese populations is crucial for informing public health strategies, especially in light of rising obesity rates.Material and methods: This retrospective study analyzed data from the CDC WONDER database to examine AMI-related mortality among obese individuals (ICD-10 codes I21 for AMI and E66 for obesity) from 1999 to 2020. Mortality rates were assessed using crude mortality rates (CMR) and age-adjusted mortality rates (AAMR) per 100,000, stratified by year, gender, race/ethnicity, state, and urban-rural status. Average annual percent change (AAPC) was calculated to identify trends over the study period.Results: From 1999 to 2020, there were 39,793 obesity-related AMI deaths. The AAPC for the entire period was 1.75 (95% CI: 1.06 to 2.45, p < 0.001). For men, the AAPC was 2.81, while for women, it was 1.12. Notably, African American individuals saw a significant increase in AMI mortality from 2018 to 2020 (AAPC = 19.28). Geographically, the Midwest, South, and West regions experienced upward trends, while the Northeast saw a slight decline. Smaller metropolitan and non-metropolitan areas showed consistent increases.Conclusions: The study highlights an upward trend in AMI-related mortality among the obese population in the U.S. from 1999 to 2020. Targeted public health interventions are needed to address these trends, particularly in high-risk populations.
- Open Access
- 1 January 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (1) , 61
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
This review provides a practical and comprehensive overview of non-pharmacological interventions for metabolic-associated fatty liver disease (MASLD), focusing on dietary and exercise strategies. It highlights the effectiveness of coffee consumption, intermittent fasting, and Mediterranean and ketogenic diets in improving metabolic and liver health. The review emphasizes the importance of combining aerobic and resistance training as a critical approach to reducing liver fat and increasing insulin sensitivity. Additionally, it discusses the synergy between diet and exercise in enhancing liver parameters and the role of gut microbiota in MASLD. The paper underscores the need for a holistic, individualized approach, integrating diet, exercise, gut health, and patient motivation. It also highlights the long-term benefits and minimal risks of lifestyle interventions compared to the side effects of pharmacological and surgical options. The review calls for personalized treatment strategies, continuous patient education, and further research to optimize therapeutic outcomes in MASLD management.
- 1 January 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (1) , 61
Open AccessNon-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
This review provides a practical and comprehensive overview of non-pharmacological interventions for metabolic-associated fatty liver disease (MASLD), focusing on dietary and exercise strategies. It highlights the effectiveness of coffee consumption, intermittent fasting, and Mediterranean and ketogenic diets in improving metabolic and liver health. The review emphasizes the importance of combining aerobic and resistance training as a critical approach to reducing liver fat and increasing insulin sensitivity. Additionally, it discusses the synergy between diet and exercise in enhancing liver parameters and the role of gut microbiota in MASLD. The paper underscores the need for a holistic, individualized approach, integrating diet, exercise, gut health, and patient motivation. It also highlights the long-term benefits and minimal risks of lifestyle interventions compared to the side effects of pharmacological and surgical options. The review calls for personalized treatment strategies, continuous patient education, and further research to optimize therapeutic outcomes in MASLD management.
- Open Access
- 14 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 2166-2168
Scrotal trichilemmal cysts: a case report
Introduction and importance: Trichilemmal cyst (TC), commonly known as the pilar cyst of the scrotum wall, is an uncommon disease. It is a type of epidermoid cyst (EC) with a benign course, and malignant change is quite rare. This disease is unusual in the scrotum; therefore, multiple cysts in the scrotum are much more unusual. There have been reports of TCs in other parts of the body, but this is the first instance of scrotal TCs in Pakistan. Case presentation: We discuss the case of a 60-year-old male patient who presented to the clinic with a right-sided scrotal swelling, which was identified as a right-sided inguinal hernia on examination, and multiple small swellings on the scrotal skin identified as TCs. The patient had scrotoplasty after hernia surgery to remove the cysts and reconstruct the excised scrotum. Following scrotoplasty, the patient’s discomfort was resolved, and cosmetic satisfaction was achieved. Clinical discussion: Excision is required if TCs become infected or for esthetic reasons. In the event of big cysts, full scrotal wall resection followed by scrotoplasty is necessary. The thigh fasciocutaneous flap is used to cover the denuded testes after scrotoplasty. The procedure’s advantages include a good outcome, low morbidity, early discharge, and great esthetic outcomes. Conclusion: We present a literature review about multiple TCs in the scrotum and their surgical management. This case will guide surgeons and future researchers in dealing with similar cases in the future.
- 14 April 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (5) , 2166-2168
Open AccessScrotal trichilemmal cysts: a case report
Introduction and importance: Trichilemmal cyst (TC), commonly known as the pilar cyst of the scrotum wall, is an uncommon disease. It is a type of epidermoid cyst (EC) with a benign course, and malignant change is quite rare. This disease is unusual in the scrotum; therefore, multiple cysts in the scrotum are much more unusual. There have been reports of TCs in other parts of the body, but this is the first instance of scrotal TCs in Pakistan. Case presentation: We discuss the case of a 60-year-old male patient who presented to the clinic with a right-sided scrotal swelling, which was identified as a right-sided inguinal hernia on examination, and multiple small swellings on the scrotal skin identified as TCs. The patient had scrotoplasty after hernia surgery to remove the cysts and reconstruct the excised scrotum. Following scrotoplasty, the patient’s discomfort was resolved, and cosmetic satisfaction was achieved. Clinical discussion: Excision is required if TCs become infected or for esthetic reasons. In the event of big cysts, full scrotal wall resection followed by scrotoplasty is necessary. The thigh fasciocutaneous flap is used to cover the denuded testes after scrotoplasty. The procedure’s advantages include a good outcome, low morbidity, early discharge, and great esthetic outcomes. Conclusion: We present a literature review about multiple TCs in the scrotum and their surgical management. This case will guide surgeons and future researchers in dealing with similar cases in the future.
- Open Access
- 27 November 2020
- Published by Springer Nature in Cureus
- Vol. 12 (11)
Non-alcoholic Fatty Liver Disease Causing Platypnea-Orthodeoxia Syndrome
Non-alcoholic fatty liver disease (NAFLD) with cryptogenic liver cirrhosis is uncommonly linked to platypnea-orthodeoxia syndrome (POS). Traditionally, this syndrome has been described in correlation to intracardiac shunting like patent foramen ovale. We report a case of a 70-year-old female, with a previous history of NAFLD and heart failure presenting with acute hypoxic respiratory failure secondary to fluid overload. Further investigations revealed cryptogenic presentation of POS, which was masked by her heart failure. The patient was not able to maintain her oxygen saturation levels in an upright position, with marked improvement when lying down. Her echocardiogram was significant for positive bubble study without any intracardiac shunt, hence making NAFLD as a cause of this rare presentation of POS a more likely diagnosis.
- 27 November 2020
- Published by Springer Nature in Cureus
- Vol. 12 (11)
Open AccessNon-alcoholic Fatty Liver Disease Causing Platypnea-Orthodeoxia Syndrome
Non-alcoholic fatty liver disease (NAFLD) with cryptogenic liver cirrhosis is uncommonly linked to platypnea-orthodeoxia syndrome (POS). Traditionally, this syndrome has been described in correlation to intracardiac shunting like patent foramen ovale. We report a case of a 70-year-old female, with a previous history of NAFLD and heart failure presenting with acute hypoxic respiratory failure secondary to fluid overload. Further investigations revealed cryptogenic presentation of POS, which was masked by her heart failure. The patient was not able to maintain her oxygen saturation levels in an upright position, with marked improvement when lying down. Her echocardiogram was significant for positive bubble study without any intracardiac shunt, hence making NAFLD as a cause of this rare presentation of POS a more likely diagnosis.
- Open Access
- 27 November 2019
- Published by Springer Nature in Cureus
- Vol. 11 (11) , e6248
A Fatal Case of Primary Orbital Ewing’s Sarcoma with Intracranial Extensions in a Six-year-old Girl
Ewing’s sarcoma (ES) is the second most common skeletal tumor seen in children and adolescents which typically involves the long bones and the axial skeleton. ES involving the orbits is extremely rare and can lead to serious consequences. Patients usually present with fever, localized bone pain which increases during the night time, and a visible mass, often with a preceding history of trauma. The diagnosis is confirmed with immunohistochemistry. Patient management involves a multidisciplinary approach with complete focal surgical excision of the tumor along with multiple chemotherapeutic agents and radiation therapy.
- 27 November 2019
- Published by Springer Nature in Cureus
- Vol. 11 (11) , e6248
Open AccessA Fatal Case of Primary Orbital Ewing’s Sarcoma with Intracranial Extensions in a Six-year-old Girl
Ewing’s sarcoma (ES) is the second most common skeletal tumor seen in children and adolescents which typically involves the long bones and the axial skeleton. ES involving the orbits is extremely rare and can lead to serious consequences. Patients usually present with fever, localized bone pain which increases during the night time, and a visible mass, often with a preceding history of trauma. The diagnosis is confirmed with immunohistochemistry. Patient management involves a multidisciplinary approach with complete focal surgical excision of the tumor along with multiple chemotherapeutic agents and radiation therapy.
- Open Access
- 22 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5457
Hyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults
Thiazide diuretics are essential first-line anti-hypertensive drugs which not only maintain blood pressure but also reduce stroke and congestive heart failure associated with morbidity and mortality in hypertensive patients. However, thiazide diuretics are associated with elevated serum uric acid (SUA) levels. This study aimed to evaluate the impact of thiazide diuretic use on their SUA levels among hypertensive individuals of Pakistan. In this cross-sectional, prospective study, adult hypertensive patients were recruited. They were divided into two groups - thiazide diuretic group and non-thiazide group. Demographic characteristics, hypertension-related characteristics, and SUA levels were included. Data were then entered and analysed using SPSS for Windows version 22.0 (IBM Corp., Armonk, NY, USA). In the thiazide group, 24.5% were hyperuricemic as compared to 15.3% in the non-thiazide group (p=0.03). The overall mean SUA levels in the thiazide group were significantly higher than those in the non-thiazide group (5.9 ± 2.1 vs. 5.3 ± 2.7 mg/dL; p=0.02). Males in the thiazide group also showed a similar pattern (5.9 ± 2.3 vs. 5.1 ± 2.1 mg/dL; p=0.02); however, the differences were insignificant in females. Patients using thiazide diuretics for one to three years were more non-hyperuricemic than hyperuricemic (p=0.000). Among hyperuricemic patients, 36.5% were taking thiazides for three to four years and 46% were taking them for more than four years (p<0.05). Hyperuricemia is a more common occurrence in thiazide diuretic users as compared to non-users. The overall sample, and men using thiazide diuretics, reported a higher mean SUA as compared to non-users. As the years of thiazide usage advanced, the number of hyperuricemic participants also significantly increased.
- 22 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5457
Open AccessHyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults
Thiazide diuretics are essential first-line anti-hypertensive drugs which not only maintain blood pressure but also reduce stroke and congestive heart failure associated with morbidity and mortality in hypertensive patients. However, thiazide diuretics are associated with elevated serum uric acid (SUA) levels. This study aimed to evaluate the impact of thiazide diuretic use on their SUA levels among hypertensive individuals of Pakistan. In this cross-sectional, prospective study, adult hypertensive patients were recruited. They were divided into two groups - thiazide diuretic group and non-thiazide group. Demographic characteristics, hypertension-related characteristics, and SUA levels were included. Data were then entered and analysed using SPSS for Windows version 22.0 (IBM Corp., Armonk, NY, USA). In the thiazide group, 24.5% were hyperuricemic as compared to 15.3% in the non-thiazide group (p=0.03). The overall mean SUA levels in the thiazide group were significantly higher than those in the non-thiazide group (5.9 ± 2.1 vs. 5.3 ± 2.7 mg/dL; p=0.02). Males in the thiazide group also showed a similar pattern (5.9 ± 2.3 vs. 5.1 ± 2.1 mg/dL; p=0.02); however, the differences were insignificant in females. Patients using thiazide diuretics for one to three years were more non-hyperuricemic than hyperuricemic (p=0.000). Among hyperuricemic patients, 36.5% were taking thiazides for three to four years and 46% were taking them for more than four years (p<0.05). Hyperuricemia is a more common occurrence in thiazide diuretic users as compared to non-users. The overall sample, and men using thiazide diuretics, reported a higher mean SUA as compared to non-users. As the years of thiazide usage advanced, the number of hyperuricemic participants also significantly increased.
- Open Access
- 21 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5447
Rheumatic Chorea as the First Presenting Sign in a 13-year-old Female Child
Rheumatic chorea (RC) is a movement disorder seen in young children and adolescents with a recent history of incompletely treated group A beta-hemolytic streptococcal (GABHS) pharyngitis. Although, it rarely presents as the first manifestation of the disease, physicians should be aware of the disease, so that early diagnosis and prompt treatment may lead to elimination of the pathogen and prevent further disease progression. We present a case of a 13-year-old female child who presented with only RC as the first clinical sign.
- 21 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5447
Open AccessRheumatic Chorea as the First Presenting Sign in a 13-year-old Female Child
Rheumatic chorea (RC) is a movement disorder seen in young children and adolescents with a recent history of incompletely treated group A beta-hemolytic streptococcal (GABHS) pharyngitis. Although, it rarely presents as the first manifestation of the disease, physicians should be aware of the disease, so that early diagnosis and prompt treatment may lead to elimination of the pathogen and prevent further disease progression. We present a case of a 13-year-old female child who presented with only RC as the first clinical sign.